Google
HYPD 株価分析 — Hyperion Defi, Inc. (Healthcare >> Biotechnology)
HYPD に関するよくある質問
HYPDのPER（株価収益率）は？
Hyperion Defi, Inc.（HYPD）は現在PER 2.61倍で取引されています。
HYPDのROE（自己資本利益率）は？
Hyperion Defi, Inc.のROEは-56.40%です。
HYPDの配当利回りは？
Hyperion Defi, Inc.の配当利回りは0.00%です。
HYPDの品質スコア（Quality Score）は？
当社のAIはHYPDの総合財務品質を100点中31点と評価しています。収益性・成長性・負債・利益の安定性に基づく評価です。
HYPDは今が買い時ですか？
当社AIのタイミングスコアは100点中27点で、テクニカル指標とモメンタムから見た現在価格の相対的な魅力度を示します。
HYPDはどのセクターに属しますか？
Hyperion Defi, Inc.はHealthcare >> Biotechnologyセクターに分類されます（NASDAQ市場）
HYPD AI Analysis Summary
Our AI summary for HYPD: Hyperion Defi, Inc. (NASDAQ), Healthcare >> Biotechnology sector. The stock currently trades at a P/E of 2.61, ROE of -56.40%, a dividend yield of 0.00%. Its financial Quality Score stands at 31/100 — fundamentals below the market average. The AI Timing Score is 27/100 — most technical signals do not support an entry at this point. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.
|
USD 2.64
Price
-0.02
(-0.75%)
Day Change
|
|
|---|
HYPD, ファンダメンタルスコアはnot good ( ファンダメンタル = 31) そして テクニカルスコアは ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROEが低い
ROAが低い
ROEの伸びが低い
平均ROEが低い
昨年度のROEが一昨年比で低い
ROAがROEに比べて低い
NPMが低い
NPMの伸びが低い
NPMの伸びが低い
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Momentum indicators aligned on the daily timeframe
In details, quality factors are not good , financial health is not good , and ability to make profit is not good , ...
| Deepscope 分析 |
|
48% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | N/A |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 2.64 |
| PBV / Sector |
0.69 / 5.20
GREAT
|
| Earning Per Share | -2.16 |
| PE / Sector |
2.61 / 19.97
GREAT
|
| PEG or PE/Growth / Sector |
-0.08 / 1.22
|
| Average 1M Daily Value |
0.69 M
GREAT
|
| Average 1W Daily Value |
0.64 M
GREAT
|
| Timing Factors |
|
42% |
| Financial Health |
|
45% |
| ポイントになる統計 |
|
47% |
| 配当 |
|
4% |
| 登録情報 |
| Analyze Date | 2026-08-01 07:59:59 |
| Symbol | HYPD |
| Name | HYPERION DEFI, INC. |
| Sector | Healthcare >> Biotechnology |
| Market | NASDAQ |
| Listed Shares | 15.16 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 40.32 / 9,903.94 |
| ニュース |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 3090 Nowitzki Way, Dallas, TX, United States, 75219
Phone: 833 393 6684
Website: https://hyperiondefi.com
Sector: Healthcare >> Biotechnology
Description: Hyperion DeFi, Inc., a DeFi company, engages in building on Hyperliquid. It operates through two segments: Ophthalmic Technology and Digital Assets. The company focuses on the long-term strategic treasury of HYPE tokens to provide simplified exposure to the Hyperliquid blockchain ecosystem. It is also developing the Optejet User Filled Device to work with various topical ophthalmic liquids, including artificial tears and lens rewetting products. The company was formerly known as Eyenovia, Inc. and changed its name to Hyperion DeFi, Inc. in July 2025. Hyperion DeFi, Inc. was founded in 2014 and is based in Dallas, Texas.
ME vs SECTOR Healthcare >> Biotechnology
Click a bubble to view stock details · Bubble size represents market capitalization share
